title: Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
authors.forename: L K
authors.initials: LK
authors.lastname: Gupta
authors.forename: V S
authors.initials: VS
authors.lastname: Randhawa
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D019540:Area Under Curve; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests / Q000592:standards*; D012485:Salmonella typhi / Q000187:drug effects*; D014435:Typhoid Fever / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin